Abstract
Using the GEP,the QSAR model for anti-cancer activity of 38 compounds in 5 cancer cell lines was establish. These compounds are a novel class of anticarcinogen named tricyclic 5:7:5-fused diimidazo [4, 5-d:4, 5-f ][1, diazepines. The carcinoma cell lines involved in this research are A549 lung cancer, MCF-7 breast cancer, MDA-MB-231 breast cancer, OVCAR-3 ovarian cancer and PC-3 prostate cancer. Accuracies of these models in training group and test group are over 90%, showing perfect predictive ability. This QSAR model will be great valuable in providing guidance for future designing and synthesizing of anticancer drugs.
Publisher
Trans Tech Publications, Ltd.
Reference13 articles.
1. J. Eckhard. RNA helicases at work: binding and rearranging. Trends in Biochemical Sciences, Vol. 6(2010), p.1371.
2. S. Rocak, P. Linder. DEAD-box proteins: the driving forces behind RNA metabolism. Nat. Rev. Mol. Cell Biol., Vol. 5(2004), pp.232-241.
3. V. Raman, A.H. Patel. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene, Vol. 27(2008), pp.3912-3922.
4. R.S. Hosmane. Potent in vitro anticancer activities of ring-expanded (fat, ) nucleosides containing the imidazo[4, 5-e][1, 3]diazepine ring system. Nucleosides, Nucleotides and Nucleic Acids, Vol. 4-7(2002), pp.1043-1045.
5. C. Ferreira. Gene expression programming: a new adaptive algorithm for solving problems. Complex Syst, Vol. 13(2001), p.87–129.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献